Recent studies have indicated that a newly identified second isoform of the tryptophan hydroxylase gene (TPH2) is preferentially involved in the rate-limiting synthesis of neuronal serotonin. Genetic variation in the human TPH2 gene (hTPH2) has been associated with altered in vitro enzyme activity as well as increased risk for mood disorders. Here, we provide the first in vivo evidence that a relatively frequent regulatory variant (G(À844)T) of hTPH2 biases the reactivity of the amygdala, a neural structure critical in the generation and regulation of emotional behaviors. Keywords: TPH2; amygdala; serotonin; fMRI Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the synthesis of serotonin (5-HT), a key modulator of mood and affect. Thus, the identification of genetic variation contributing to functional changes in TPH enzymatic activity is of great interest in determining the biological pathways underpinning individual differences in emotional behaviors and risk for psychiatric disorders, including depression, anxiety, and suicidality. Recent molecular and cellular studies have revealed the existence of a second TPH isoform, tryptophan hydroxylase-2 (TPH2), exclusively expressed in the murine brain. 1 Functional assays demonstrate that TPH2-and not the original isoform, referred to now as TPH1-is responsible for regulating TPH expression and 5-HT synthesis in the murine central nervous system. 2 In contrast, both TPH1 and TPH2 are expressed in the human brain 3 and genetic variation in both isoforms have been associated with alterations in mood and 5-HT function. 4,5 Furthermore, a relatively rare single nucleotide polymorphism in human TPH2 (hTPH2) associated with depression has been shown to alter TPH enzymatic efficiency in vitro. 6 However, the functional consequence of genetic variation in hTPH2 on the neural circuitry of mood and emotional behaviors is unknown.In the current study, we used functional magnetic resonance imaging (fMRI) to examine the effects of a single nucleotide polymorphism (G(À844)T) in the upstream regulatory region of hTPH2 on the reactivity of the amygdala, a central structure in the mediation of behavioral and physiologic arousal associated with emotional behaviors. Although the molecular and cellular effects of the G(À844)T polymorphism are unknown, we focused on this regulatory variant for several reasons. First, unlike other hTPH2 variants with demonstrated impact on enzymatic activity, 6 the G(À844)T has a relatively high minor allele frequency (T allele ¼ 38%) and thus, has the potential to contribute more broadly to brain function and risk for mood disorders. Second, this variant is located within 1 kb (844 bp upstream) of the transcription initiation site of hTPH2 and is likely a constituent of the proximal promoter of the gene. Regulatory variants in general often impact gene expression 7 and several specific promoter polymorphisms in other 5-HT subsystem genes have demonstrated effects on brain function and emotional behaviors. [8][9][10]